SynAct Pharma AB’s Listing on on Nasdaq Stockholm

Setterwalls has advised SynAct Pharma AB.SynAct Pharma AB announced the listing of the company’s shares on Nasdaq Stockholm, Mid Cap. The trading on Nasdaq Stockholm commenced on…

This content is for Standard 1 Year members only.
Login Join Now

Midas’ $45 Million Series A Funding Round

Vehicle Accessories’ Acquisition of Maxton Group

Lumana’s $24 Million Series Seed Financing

Opea Securitizadora’s R$120 Million Real Estate Receivables Certificates Issuance

Grupo De Inversiones Suramericana (Grupo SURA)’s $500 Million Loan

G Mining Ventures Corp.’s Combination With Reunion Gold Corporation

Five Tech’s Acquisition of Box Limited

CureVac’s Collaboration with MD Anderson

Sartorius Group’s Agreement And Minority Investment With TheWell Bioscience Inc.

KOKO Networks Limited’s Financing Round

India Vehicle Finance’s Notes Offering

Al-Arafa’s Demerger into Concrete Fashion Group and GTEX

SC Ventures’ $100 Million Joint Venture With SBI Holdings

GreenCorp’s Acquisition of Emad Bakeries

MedOne’s Agreement with Shikun and Binui Energy

Apple South Asia’s Investment in Clean Max Hyperion Power

ReNew Energy Global’s Transaction Agreement with JERA

AG&P LNG Marketing’s Investment Round

Securities Regulation Partner Emily Gordy Joins King & Spalding in Washington, D.C.

Labor and Employment Lawyer Sydney Jones Lampard Joins King & Spalding in Washington, D.C.

Hefesto Asesores continues to consolidate its position in the International Private Equity and Venture Capital market, with the formation of Hefesto Global

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.

Securities Regulation Partner Emily Gordy Joins King & Spalding in Washington, D.C.

Labor and Employment Lawyer Sydney Jones Lampard Joins King & Spalding in Washington, D.C.

Paul Hastings Adds Premier Private Equity Buyout Team

SynAct Pharma AB’s Listing on on Nasdaq Stockholm

Author: Federica Tiefenthaler